Post by
faraj69 on Jul 11, 2016 12:27pm
Ipsen hires David Meek as CEO
https://www.nasdaq.com/article/ipsen-names-david-meek-ceo-effective-july-18---quick-facts-20160711-00013
Comment by
TigerDawn on Jul 11, 2016 3:45pm
Well, that certainly looks like Ipsen have set their eyes on North America. Quizzically optimistic.
Comment by
finetimetoleave on Jul 11, 2016 3:52pm
bettiing they aren't paying out to tst for the rights on the product- cheaper to buy them out and signed a deal - just what that amount is a question mark i would say as a good guess tst took the offer and we wait for the anouncement
Comment by
faraj69 on Jul 12, 2016 12:05am
I'll tell you how much... https://www.bloomberg.com/news/articles/2016-01-19/ipsen-to-step-up-deal-making-scout-for-new-cancer-products Also fits the timeline for FDA approval for MCNA. Can an all mean nothing but I'm just saying.
Comment by
peasoupfog on Jul 12, 2016 7:20pm
This post has been removed in accordance with Community Policy
Comment by
blartar on Jul 12, 2016 9:14pm
100 % right on !!! Now if we see them issue themselves millions of options at 5-7 cents, then it is possible we are about to get some news in the next few months that would cause a spike to 15 cents or so, so they get out at a profit. JMHO
Comment by
finetimetoleave on Jul 12, 2016 10:18pm
i will explain it to you so that even you can understand. ipsen did not go into thisblindly hoping. They were positive that in the countries that they had been given the rights for that they would not have a problem. the way you portray it is as if they gambled. LOL that is the joke. big companies dont play - they can shelf this thing if they want to
Comment by
peasoupfog on Jul 12, 2016 11:30pm
This post has been removed in accordance with Community Policy